IMMUNE THROMBOCYTOPENIA (ITP)
Clinical trials for IMMUNE THROMBOCYTOPENIA (ITP) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on stubborn bleeding disorder
Disease control Not yet recruitingThis early-phase study tests a new treatment called QT-019C for adults with refractory immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The therapy uses donor-derived CAR T-cells designed to target and remove faulty immune c…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New drug golidocitinib tested for Hard-to-Treat ITP
Disease control Not yet recruitingThis study tests an experimental drug, golidocitinib, in 138 adults with primary immune thrombocytopenia (ITP) whose platelet counts remain low despite prior treatments. The study has two parts: first, finding a safe dose, then comparing the drug to a placebo in a blinded fashion…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Real-World ITP treatment patterns under review in china
Knowledge-focused Not yet recruitingThis study collects information from medical records of about 500 patients with immune thrombocytopenia (ITP) to see what treatments they received and how well they worked. It includes both treated and untreated patients aged 6 and older. The goal is to learn about current treatm…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC